· 自动抓取 · 最新研究 · 1 分钟阅读
Chimeric antigen receptor T-cell therapy is equally effective and safe in older (≥70) and younger patients with multiple myeloma: a multicenter retrospective analysis
Blood Cancer Journal, Published online: 02 June 2026; doi:10.1038/s41408-026-01531-wChimeric antigen receptor T-cell therapy is equally effective and safe in older (≥70) and younger patients with mult
Blood Cancer Journal, Published online: 02 June 2026; doi:10.1038/s41408-026-01531-wChimeric antigen receptor T-cell therapy is equally effective and safe in older (≥70) and younger patients with multiple myeloma: a multicenter retrospective analysis
本文自动抓取自 Blood Cancer Journal，原文链接：Chimeric antigen receptor T-cell therapy is equally effective and safe in older (≥70) and younger patients with multiple myeloma: a multicenter retrospective analysis
原文发布日期：2026-06-02
Share:
